LMH STRATEGIC SOLUTIONS

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Biopharmaceutical industry trade association.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jan 12, 2026

Bills named in this filing 3

HR 2213
Medical Supply Chain Resiliency Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S 832
EPIC Act of 2025

Lobbying activity 2

Medicare/Medicaid

General Medicare and Medicaid Issues.

Pharmacy

Pharmaceutical Supply Chain. H.R.2213 - Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832 - EPIC Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.